Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Pilot Non-inferiority Study Investigating Daily Versus Every Other Day Dosing of Oral Iron in Premature Infants.
CHRISTUS Health
100 participants
Aug 1, 2024
INTERVENTIONAL
Conditions
Summary
Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates
Eligibility
Inclusion Criteria5
- Children (Minor \< 18 years of age)
- Neonates
- Hospitalized
- Premature infants who are on full enteral feeds and are started on oral iron
- Premature infants who completed 26 0/7 to 32 6/7 weeks' gestation at birth
Exclusion Criteria1
- • Infants with known congenital anomalies or chromosomal abnormalities (such as Trisomy 18 or Trisomy 21), conditions that affect iron metabolism (such as thalassemia or hemochromatosis), bleeding disorders or coagulopathy, and received iron parenterally prior to randomization
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
6mg/kg of oral iron as ferrous sulfate administered every other day instead of 6 mg/kg of oral iron daily supplementation.
6 mg/kg of oral iron as daily ferrous sulfate instead of 6mg/kg of oral iron supplementation administered every other day.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06555315